Department of Medicine

June 14, 2018

VUMC joins research network to fight atrial fibrillation

Vanderbilt University Medical Center (VUMC) has been selected by the American Heart Association (AHA) to participate in a six-member research network to advance treatment and prevention of atrial fibrillation (AFib), an irregular heart rate that increases the risk of stroke and other heart-related complications.

By Bill Snyder
June 14, 2018

State of the Department of Medicine address reviews achievement, challenges

Nancy Brown, M.D., Hugh J. Morgan Professor and chair of the Department of Medicine in the Vanderbilt University School of Medicine, delivered a mixture of accolades and challenges to the dozens of faculty members, residents and fellows who attended her annual State of the Department address last week in Langford Auditorium.

By Bill Snyder
June 14, 2018

Lung cancer patients and advocates visit VUMC research labs

A group of young lung cancer patients and their family members recently toured research laboratories at Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center (VICC) to learn how investigators are working to find better therapies and possibly a cure for the disease.

By VUMC News and Communications
June 7, 2018

How providers receive feedback plays crucial role in antimicrobial stewardship programs

Antimicrobial resistance continues to increase, and antimicrobial stewardship programs are developing plans to report antimicrobial use in order to reduce and optimize the use of antibiotics.

By Matt Batcheldor
June 7, 2018

Enzyme protects against obesity-related heart disease

Vanderbilt scientists have discovered that a certain enzyme plays a crucial role in preventing obesity-related cardiac dysfunction.

By Sanjay Mishra
May 31, 2018

Team seeks to shed light on rare immune-mediated adverse drug reaction

Thirty years ago when she was 16, Katie Niemeyer was prescribed carbamazepine for depression. Three weeks later she was in a St. Louis, Missouri, burn unit with second and third degree burns all over her body. “My parents were told the chances of me surviving were slim,” she said.

By Bill Snyder
May 29, 2018

Berlin assumes new VICC leadership post

Jordan Berlin, MD, has been named associate director of Clinical Investigation Strategy and Shared Resources at Vanderbilt-Ingram Cancer Center (VICC).
By Doug Campbell
May 29, 2018

New research finds lung cancer risk drops substantially within five years of quitting smoking

Just because you stopped smoking years ago doesn’t mean you’re out of the woods when it comes to developing lung cancer.  That’s the “bad” news. The good news is your risk of lung cancer drops substantially within five years of quitting.
By Bill Snyder
May 23, 2018

Evolution of a deadly virus

Genomic sequences have revealed that Florida is a major source of a mosquito-borne virus that causes disease in horses and humans.
By Leigh MacMillan
May 17, 2018

Park named to VICC breast cancer leadership position

By Doug Campbell
May 10, 2018

Honoring Robertson

David Robertson, MD, second from left, poses with three longtime colleagues who spoke during last week’s symposium honoring his scientific legacy.
By Bill Snyder
May 10, 2018

Grant bolsters kidney cancer immunotherapy research

W. Kimryn Rathmell, MD, PhD, Cornelius Abernathy Craig Professor of Medicine and director of the Division of Hematology and Oncology at Vanderbilt-Ingram Cancer Center (VICC), has received a grant to research the role of immunosuppression in the tumor microenvironment for kidney cancer.
By Doug Campbell
May 7, 2018

Records point to drug-drug interaction

Patients who take a cholesterol-lowering statin drug while taking the antibiotic daptomycin have increased risk of developing muscle weakness or a more severe form of muscle damage.
By Paul Govern
1 … 82 83 84 85 86 … 125